Holen Sie sich die Stockscreener-App
468.00
1.90%
8.71
Handel nachbörslich:
468.00
Schlusskurs vom Vortag:
$459.29
Offen:
$461.7
24-Stunden-Volumen:
517.58K
Relative Volume:
1.10
Marktkapitalisierung:
$13.15B
Einnahmen:
$2.16B
Nettoeinkommen (Verlust:
$416.39M
KGV:
35.73
EPS:
13.1
Netto-Cashflow:
$540.93M
1W Leistung:
+8.74%
1M Leistung:
+44.67%
6M Leistung:
+36.68%
1J Leistung:
+21.82%
1-Tages-Spanne:
$460.83
$470.79
1-Wochen-Bereich:
$424.63
$470.79
52-Wochen-Spanne:
$250.05
$501.30
Medpace Holdings Inc Stock (MEDP) Company Profile
Firmenname
Medpace Holdings Inc
Sektor
Branche
Telefon
(513) 579-9911
Adresse
5375 MEDPACE WAY, CINCINNATI, OH
Vergleichen Sie MEDP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MEDP
Medpace Holdings Inc
|
468.00 | 12.90B | 2.16B | 416.39M | 540.93M | 13.10 |
|
TMO
Thermo Fisher Scientific Inc
|
484.79 | 180.28B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
209.14 | 147.31B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
663.92 | 52.18B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
120.29 | 33.33B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
190.23 | 31.60B | 15.50B | 1.33B | 2.16B | 7.34 |
Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-29 | Herabstufung | UBS | Neutral → Sell |
| 2025-07-23 | Herabstufung | TD Cowen | Hold → Sell |
| 2025-06-24 | Eingeleitet | Barclays | Equal Weight |
| 2025-04-22 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-04-14 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-03-24 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-10-23 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-09-27 | Herabstufung | UBS | Buy → Neutral |
| 2024-09-25 | Herabstufung | Jefferies | Buy → Hold |
| 2024-08-01 | Eingeleitet | Truist | Hold |
| 2024-05-29 | Eingeleitet | TD Cowen | Buy |
| 2024-05-28 | Eingeleitet | Mizuho | Buy |
| 2024-04-23 | Hochstufung | Jefferies | Hold → Buy |
| 2024-03-18 | Eingeleitet | Deutsche Bank | Hold |
| 2024-02-15 | Hochstufung | UBS | Neutral → Buy |
| 2023-10-24 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2023-05-08 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-10-27 | Hochstufung | UBS | Sell → Neutral |
| 2022-09-07 | Eingeleitet | UBS | Sell |
| 2022-05-24 | Eingeleitet | Guggenheim | Neutral |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-10-02 | Hochstufung | Truist | Hold → Buy |
| 2020-06-08 | Hochstufung | Robert W. Baird | Underperform → Neutral |
| 2020-05-13 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-04-30 | Hochstufung | SunTrust | Sell → Hold |
| 2020-04-20 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2020-03-17 | Herabstufung | SunTrust | Hold → Sell |
| 2020-01-27 | Herabstufung | SunTrust | Buy → Hold |
| 2018-10-31 | Hochstufung | SunTrust | Hold → Buy |
| 2018-09-17 | Eingeleitet | SunTrust | Hold |
| 2018-07-31 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2017-11-01 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2017-09-29 | Eingeleitet | Raymond James | Mkt Perform |
| 2017-07-10 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
Alle ansehen
Medpace Holdings Inc Aktie (MEDP) Neueste Nachrichten
Medpace Volume Surges 63.22% to $240M Ranks 485th in Market Activity as Institutional Capital Flows In - AInvest
Medpace Shares Rally 3.55% on $250M Volume Ranking 406th as Liquidity-Driven Strategy Surpasses Benchmark by 137.53 - AInvest
Earnings Not Telling The Story For Medpace Holdings, Inc. (NASDAQ:MEDP) After Shares Rise 34% - simplywall.st
Medpace slips as UBS cuts to Sell despite strong Q2 results - MSN
Should You Buy Medpace (MEDP) After Golden Cross? - MSN
Can Medpace Holdings Inc. Rally Enough to Break EvenSector Based Breakout Stock Forecast Issued - beatles.ru
Medpace Surprises with Double-Digit Revenue Growth in Q2 2025 - AInvest
Medpace: Return Of The Mack, With Double-Digit Revenue Growth (NASDAQ:MEDP) - Seeking Alpha
Should I hold or sell Medpace Holdings Inc. stock in 2025Free Stock Market Real-Time Monitoring - Jammu Links News
How volatile is Medpace Holdings Inc. stock compared to the marketRapid market gains - Jammu Links News
Published on: 2025-08-04 02:37:58 - Jammu Links News
What catalysts could drive Medpace Holdings Inc. stock higher in 2025Capitalize on momentum-driven opportunities - Jammu Links News
Does Medpace Holdings Inc. stock perform well during market downturnsInvest in stocks with strong fundamentals - Jammu Links News
What drives Medpace Holdings Inc. stock priceDiscover stocks with explosive upside potential - Jammu Links News
Is Medpace Holdings Inc. stock overvalued or undervaluedMarket-leading profit generation - Jammu Links News
What institutional investors are buying Medpace Holdings Inc. stockBuild wealth steadily with smart stock selection - Jammu Links News
Is it the right time to buy Medpace Holdings Inc. stockBuild wealth with professional market analysis - Jammu Links News
Medpace Holdings Inc. Rebound Backed by Sentiment ShiftBuy Signal Based on Chart Analysis Confirmed - beatles.ru
What makes Medpace Holdings Inc. stock price move sharplyStable Growth Stock Overview Strategy - beatles.ru
Identifying reversal signals in Medpace Holdings Inc.Real Time Stock Movement Analysis Indicates Breakout - metal.it
How does Medpace Holdings Inc. generate profit in a changing economyDaily Trading Picks With High Returns - Jammu Links News
Have Medpace Holdings Insiders Been Selling Stock? - 富途牛牛
Has Medpace Holdings Inc. Stock Ever Crashed Historical Volatility ReviewChart Driven High Reward Trading Setup Presented - beatles.ru
Medpace Hldgs Insider Sells $21.9M Worth of Stock - AInvest
How Medpace Holdings Inc. stock performs during market volatilityShort Term Buy Zone Stock Alerts Signal Entry - metal.it
Institutional Tools Highlight Unusual Flow in Medpace Holdings Inc.Swing Trading Plan With Smart Signals in Review - metal.it
Medpace general counsel Ewald sells $1.35m in stock - Investing.com
Medpace general counsel Ewald sells $1.35m in stock By Investing.com - Investing.com South Africa
Insider Selling at Medpace Holdings: Distinguishing Routine Moves from Red Flags - AInvest
Medpace stock slips as UBS cuts to Sell (MEDP:NASDAQ) - Seeking Alpha
Why Medpace (MEDP) Stock Is Trading Lower Today - TradingView
MEDP: UBS Downgrades Medpace Holdings, Raises Price Target | MED - GuruFocus
Medpace stock rating downgraded to Sell by UBS on ambitious targets - Investing.com Nigeria
Decoding Insider Selling at Medpace Holdings: A Strategic Investment Analysis - AInvest
North America Clinical Trials Market Forecast and Company Analysis Report 2025-2033 Featuring ICON, Wuxi AppTec, SGS, Syneos Health, PRA Health Sciences, Pfizer, IQVIA, and Medpace - Yahoo Finance
What Makes Medpace (MEDP) a New Strong Buy Stock - sharewise.com
Best Momentum Stocks to Buy for July 28th - TradingView
New Strong Buy Stocks for July 28th - TradingView
Why is Medpace Holdings Inc. stock attracting strong analyst attentionBest Dividend Forecasts To Watch Now - jammulinksnews.com
Medpace Holdings, Inc. Reports Strong Q2 Earnings and Market ResponseNews and Statistics - IndexBox
Finanzdaten der Medpace Holdings Inc-Aktie (MEDP)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.96%
1.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):